LV11898A - Eritromicina atvasinajumi - Google Patents

Eritromicina atvasinajumi

Info

Publication number
LV11898A
LV11898A LV970137A LV970137A LV11898A LV 11898 A LV11898 A LV 11898A LV 970137 A LV970137 A LV 970137A LV 970137 A LV970137 A LV 970137A LV 11898 A LV11898 A LV 11898A
Authority
LV
Latvia
Prior art keywords
erythromycin derivatives
erythromycin
derivatives
Prior art date
Application number
LV970137A
Other languages
English (en)
Other versions
LV11898B (lv
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of LV11898A publication Critical patent/LV11898A/lv
Publication of LV11898B publication Critical patent/LV11898B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LVP-97-137A 1994-12-13 1997-07-10 Eritromicīna atvasinājumi LV11898B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (2)

Publication Number Publication Date
LV11898A true LV11898A (lv) 1997-12-20
LV11898B LV11898B (lv) 1998-03-20

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-137A LV11898B (lv) 1994-12-13 1997-07-10 Eritromicīna atvasinājumi

Country Status (35)

Country Link
US (1) US5847092A (lv)
EP (1) EP0797579B1 (lv)
JP (1) JPH10510520A (lv)
KR (1) KR100367559B1 (lv)
CN (1) CN1046535C (lv)
AP (1) AP739A (lv)
AT (1) ATE190620T1 (lv)
AU (1) AU690791B2 (lv)
BG (1) BG63261B1 (lv)
BR (1) BR9510015A (lv)
CA (1) CA2207029A1 (lv)
CZ (1) CZ289943B6 (lv)
DE (1) DE69515694T2 (lv)
DK (1) DK0797579T3 (lv)
EE (1) EE03401B1 (lv)
ES (1) ES2144154T3 (lv)
FI (1) FI972493A0 (lv)
GE (1) GEP20012391B (lv)
GR (1) GR3033622T3 (lv)
HU (1) HU220631B1 (lv)
IT (1) IT1276901B1 (lv)
LT (1) LT4276B (lv)
LV (1) LV11898B (lv)
MD (1) MD1788G2 (lv)
NO (1) NO309816B1 (lv)
NZ (1) NZ297446A (lv)
OA (1) OA10491A (lv)
PL (1) PL182053B1 (lv)
PT (1) PT797579E (lv)
RO (1) RO116282B1 (lv)
RU (1) RU2152951C1 (lv)
SI (1) SI9520124A (lv)
TJ (1) TJ306B (lv)
UA (1) UA48958C2 (lv)
WO (1) WO1996018633A1 (lv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
KR880009960A (ko) 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin

Also Published As

Publication number Publication date
BG63261B1 (bg) 2001-07-31
AP9700989A0 (en) 1997-07-31
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
CN1169727A (zh) 1998-01-07
CN1046535C (zh) 1999-11-17
TJ306B (en) 2001-08-06
FI972493A (fi) 1997-06-12
IT1276901B1 (it) 1997-11-03
RU2152951C1 (ru) 2000-07-20
DK0797579T3 (da) 2000-06-05
HUT77126A (hu) 1998-03-02
NZ297446A (en) 1999-06-29
PL320688A1 (en) 1997-10-27
CA2207029A1 (en) 1996-06-20
ITMI942496A1 (it) 1996-06-13
UA48958C2 (uk) 2002-09-16
EP0797579B1 (en) 2000-03-15
AU690791B2 (en) 1998-04-30
DE69515694T2 (de) 2000-10-26
PL182053B1 (pl) 2001-10-31
ITMI942496A0 (it) 1994-12-13
MD970243A (en) 1999-05-31
FI972493A0 (fi) 1997-06-12
DE69515694D1 (de) 2000-04-20
ATE190620T1 (de) 2000-04-15
LT4276B (lt) 1998-01-26
KR100367559B1 (ko) 2003-04-21
EE9700124A (et) 1997-12-15
SI9520124A (sl) 1998-04-30
NO972702D0 (no) 1997-06-12
CZ289943B6 (cs) 2002-04-17
CZ178697A3 (en) 1997-12-17
BG101570A (en) 1998-02-27
PT797579E (pt) 2000-08-31
US5847092A (en) 1998-12-08
JPH10510520A (ja) 1998-10-13
BR9510015A (pt) 1997-10-28
OA10491A (en) 2002-04-10
HU220631B1 (hu) 2002-03-28
EP0797579A1 (en) 1997-10-01
RO116282B1 (ro) 2000-12-29
GR3033622T3 (en) 2000-10-31
ES2144154T3 (es) 2000-06-01
WO1996018633A1 (en) 1996-06-20
NO309816B1 (no) 2001-04-02
AU4260396A (en) 1996-07-03
GEP20012391B (en) 2001-03-25
LT97116A (en) 1997-10-27
NO972702L (no) 1997-08-13
LV11898B (lv) 1998-03-20
EE03401B1 (et) 2001-04-16
MX9704253A (es) 1997-09-30
AP739A (en) 1999-03-24

Similar Documents

Publication Publication Date Title
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
LV11739A (lv) Eritromicina atvasinajumi iegusanas panemiens un pielietojums
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
DE69522717D1 (de) Chinazolinderivate
DE122009000076I1 (de) Chinazolin-derivate
DE69610698T2 (de) Chinazolin-derivate
IS5251A (is) 9-oxím erýþrómýsín afleiður
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DE69430587T2 (de) Pyrimidin-acyclonukleosid-derivate
BR9509793A (pt) Derivados de tiofeneno
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
LV11898A (lv) Eritromicina atvasinajumi
ATE240307T1 (de) Diarylalkenylamin-derivate
DE69527786T2 (de) Diaminomethyliden-derivate
BR9507016A (pt) Derivados de oxima
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69511993D1 (de) Antineoplastische Cyclolignan-Derivate